CORRESP Filing
BriaCell Therapeutics Corp.
Date: Jan. 6, 2026 · CIK: 0001610820 · Accession: 0001493152-26-000535
AI Filing Summary & Sentiment
File numbers found in text: 333-292388
Show Raw Text
CORRESP
1
filename1.htm
ThinkEquity
LLC
17
State Street, 41 st Floor
New
York, NY 10004
January
6, 2026
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street NE
Washington,
D.C. 20549
Attention:
Alan Campbell
Re:
BriaCell
Therapeutics Corp. (the "Company")
Registration
Statement on Form S-1 (the "Registration Statement")
File
No. 333-292388
Ladies
and Gentlemen:
ThinkEquity
LLC ("ThinkEquity"), solely acting as placement agent on a best efforts basis in an offering pursuant to the Registration
Statement, hereby concurs in the request by the Company that the effective date of the above-referenced Registration Statement be accelerated
to 5:00 p.m. Eastern Time on January 8, 2026, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to
such time pursuant to Rule 461 under the Securities Act of 1933 (the "Securities Act").
ThinkEquity
affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration
Statement.
Very
truly yours,
ThinkEquity
LLC
/s/
Eric Lord
Eric
Lord
Head of Investment Banking